Cargando…

Smoke-Free Policies and 30-Day Mortality Rates for Chronic Obstructive Pulmonary Disease

Background: Smoke-free policies have been shown to impact 30-day readmission rates due to chronic obstructive pulmonary disease (COPD) among adults aged ≥65 years. However, little is known about the association between smokefree policies and 30-day mortality rates for COPD. Therefore, we investigate...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamadi, Hanadi, Stallings-Smith, Sericea, Apatu, Emma, Peterson, Breck, Spaulding, Aaron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kerman University of Medical Sciences 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808222/
https://www.ncbi.nlm.nih.gov/pubmed/34380194
http://dx.doi.org/10.34172/ijhpm.2021.74
_version_ 1784862891847974912
author Hamadi, Hanadi
Stallings-Smith, Sericea
Apatu, Emma
Peterson, Breck
Spaulding, Aaron
author_facet Hamadi, Hanadi
Stallings-Smith, Sericea
Apatu, Emma
Peterson, Breck
Spaulding, Aaron
author_sort Hamadi, Hanadi
collection PubMed
description Background: Smoke-free policies have been shown to impact 30-day readmission rates due to chronic obstructive pulmonary disease (COPD) among adults aged ≥65 years. However, little is known about the association between smokefree policies and 30-day mortality rates for COPD. Therefore, we investigated the association between comprehensive smoke-free policies and 30-day mortality rates for COPD. Methods: We used a cross-sectional study design and retrospectively examined risk-adjusted 30-day mortality rates for COPD across US hospitals in 1171 counties. Data were sourced from Centers for Medicare and Medicaid Services (CMS) Hospital Value-Based Purchasing (HVBP) Program, American Hospital Association (AHA) Annual Surveys, US Census Bureau Current Population Survey, and US Tobacco Control Laws Database from the American Nonsmokers’ Rights Foundation (ANRF). Data were averaged at the county level for years 2015-2018. Hierarchical Poisson models adjusted for differences in hospital characteristics and accounted for the clustering of hospitals within a county were used. Results: Our findings show a consistent association between stronger smoke-free policies and a reduction in COPD mortality. When evaluating smoke-free policy, county characteristics, and hospital characteristics individually, we found that counties with full coverage or partial coverage had a reduced incidence rate of COPD mortality compared to no coverage counties. After adjusting for the county and hospital characteristics, counties with full coverage of smoke-free policies had a reduced rate of 30-day COPD mortality (adjusted incidence rate ratio [IRR]: 0.87, 95% CI: 0.79, 0.96) compared to counties with no policy coverage. Conclusion: Comprehensive smoke-free policies are associated with a reduction in 30-day mortality following hospital admission for COPD. Partial smoke-free legislation is an insufficient preventative measure. These findings have strong implications for hospital policy-makers, suggesting that policy interventions to reduce COPD-related 30-day mortality should include implementing smoke-free policies and public health policy-makers to incentivize comprehensive smokefree policies.
format Online
Article
Text
id pubmed-9808222
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Kerman University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-98082222023-01-10 Smoke-Free Policies and 30-Day Mortality Rates for Chronic Obstructive Pulmonary Disease Hamadi, Hanadi Stallings-Smith, Sericea Apatu, Emma Peterson, Breck Spaulding, Aaron Int J Health Policy Manag Original Article Background: Smoke-free policies have been shown to impact 30-day readmission rates due to chronic obstructive pulmonary disease (COPD) among adults aged ≥65 years. However, little is known about the association between smokefree policies and 30-day mortality rates for COPD. Therefore, we investigated the association between comprehensive smoke-free policies and 30-day mortality rates for COPD. Methods: We used a cross-sectional study design and retrospectively examined risk-adjusted 30-day mortality rates for COPD across US hospitals in 1171 counties. Data were sourced from Centers for Medicare and Medicaid Services (CMS) Hospital Value-Based Purchasing (HVBP) Program, American Hospital Association (AHA) Annual Surveys, US Census Bureau Current Population Survey, and US Tobacco Control Laws Database from the American Nonsmokers’ Rights Foundation (ANRF). Data were averaged at the county level for years 2015-2018. Hierarchical Poisson models adjusted for differences in hospital characteristics and accounted for the clustering of hospitals within a county were used. Results: Our findings show a consistent association between stronger smoke-free policies and a reduction in COPD mortality. When evaluating smoke-free policy, county characteristics, and hospital characteristics individually, we found that counties with full coverage or partial coverage had a reduced incidence rate of COPD mortality compared to no coverage counties. After adjusting for the county and hospital characteristics, counties with full coverage of smoke-free policies had a reduced rate of 30-day COPD mortality (adjusted incidence rate ratio [IRR]: 0.87, 95% CI: 0.79, 0.96) compared to counties with no policy coverage. Conclusion: Comprehensive smoke-free policies are associated with a reduction in 30-day mortality following hospital admission for COPD. Partial smoke-free legislation is an insufficient preventative measure. These findings have strong implications for hospital policy-makers, suggesting that policy interventions to reduce COPD-related 30-day mortality should include implementing smoke-free policies and public health policy-makers to incentivize comprehensive smokefree policies. Kerman University of Medical Sciences 2021-07-14 /pmc/articles/PMC9808222/ /pubmed/34380194 http://dx.doi.org/10.34172/ijhpm.2021.74 Text en © 2022 The Author(s); Published by Kerman University of Medical Sciences https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Hamadi, Hanadi
Stallings-Smith, Sericea
Apatu, Emma
Peterson, Breck
Spaulding, Aaron
Smoke-Free Policies and 30-Day Mortality Rates for Chronic Obstructive Pulmonary Disease
title Smoke-Free Policies and 30-Day Mortality Rates for Chronic Obstructive Pulmonary Disease
title_full Smoke-Free Policies and 30-Day Mortality Rates for Chronic Obstructive Pulmonary Disease
title_fullStr Smoke-Free Policies and 30-Day Mortality Rates for Chronic Obstructive Pulmonary Disease
title_full_unstemmed Smoke-Free Policies and 30-Day Mortality Rates for Chronic Obstructive Pulmonary Disease
title_short Smoke-Free Policies and 30-Day Mortality Rates for Chronic Obstructive Pulmonary Disease
title_sort smoke-free policies and 30-day mortality rates for chronic obstructive pulmonary disease
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808222/
https://www.ncbi.nlm.nih.gov/pubmed/34380194
http://dx.doi.org/10.34172/ijhpm.2021.74
work_keys_str_mv AT hamadihanadi smokefreepoliciesand30daymortalityratesforchronicobstructivepulmonarydisease
AT stallingssmithsericea smokefreepoliciesand30daymortalityratesforchronicobstructivepulmonarydisease
AT apatuemma smokefreepoliciesand30daymortalityratesforchronicobstructivepulmonarydisease
AT petersonbreck smokefreepoliciesand30daymortalityratesforchronicobstructivepulmonarydisease
AT spauldingaaron smokefreepoliciesand30daymortalityratesforchronicobstructivepulmonarydisease